These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9099290)

  • 21. Symptomatic and asymptomatic visual loss in patients taking vigabatrin.
    Daneshvar H; Racette L; Coupland SG; Kertes PJ; Guberman A; Zackon D
    Ophthalmology; 1999 Sep; 106(9):1792-8. PubMed ID: 10485552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of abnormal vision in one-year-old Thai children, based on a prospective cohort study of Thai children (PCTC).
    Tengtrisorn S; Singha P; Chuprapawan C
    J Med Assoc Thai; 2005 Nov; 88 Suppl 9():S114-20. PubMed ID: 16681062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Visual function and visual perception in cerebral palsied children.
    Kozeis N; Anogeianaki A; Mitova DT; Anogianakis G; Mitov T; Klisarova A
    Ophthalmic Physiol Opt; 2007 Jan; 27(1):44-53. PubMed ID: 17239189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spectrum of visual disorders in children with cerebral visual impairment.
    Fazzi E; Signorini SG; Bova SM; La Piana R; Ondei P; Bertone C; Misefari W; Bianchi PE
    J Child Neurol; 2007 Mar; 22(3):294-301. PubMed ID: 17621499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional vision loss: a diagnosis of exclusion.
    Villegas RB; Ilsen PF
    Optometry; 2007 Oct; 78(10):523-33. PubMed ID: 17904493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical ability of pattern electroretinograms and visual evoked potentials in detecting visual dysfunction in ocular hypertension and glaucoma.
    Parisi V; Miglior S; Manni G; Centofanti M; Bucci MG
    Ophthalmology; 2006 Feb; 113(2):216-28. PubMed ID: 16406535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progression of visual field defects in leber hereditary optic neuropathy: experience of the LHON treatment trial.
    Newman NJ; Biousse V; Newman SA; Bhatti MT; Hamilton SR; Farris BK; Lesser RL; Turbin RE
    Am J Ophthalmol; 2006 Jun; 141(6):1061-1067. PubMed ID: 16765674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blue filter amblyopia treatment protocol for strabismic amblyopia: a prospective comparative study of 50 cases.
    Metzler U; Ham O; Flores V; Claramunt M; Sepulveda C; Casanova D
    Binocul Vis Strabismus Q; 1998; 13(4):241-8. PubMed ID: 9852438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Functional eye testing in the mentally retarded].
    Van Hof-Van Duin J; Mohn G; Batenburg-Plenter AM
    Tijdschr Kindergeneeskd; 1982 Apr; 50(2):46-52. PubMed ID: 7123535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychogenic visual disorders in an abused child: a case report.
    Berman RJ
    Am J Optom Physiol Opt; 1978 Oct; 55(10):735-8. PubMed ID: 747201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reading performance in patients with retinitis pigmentosa: a study using the MNREAD charts.
    Virgili G; Pierrottet C; Parmeggiani F; Pennino M; Giacomelli G; Steindler P; Menchini U; Orzalesi N;
    Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3418-24. PubMed ID: 15452044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Severe visual impairment of children with hydrocephalus and concomitant diseases].
    Pojda-Wilczek D; Kicińska A; Krupińska N
    Klin Oczna; 2004; 106(4-5):577-9. PubMed ID: 15646472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness analysis in glaucoma: what drives utility? Results from a pilot study in Sweden.
    Kobelt G; Jonsson B; Bergström A; Chen E; Lindén C; Alm A
    Acta Ophthalmol Scand; 2006 Jun; 84(3):363-71. PubMed ID: 16704699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The reliability of frequency-doubling technology (FDT) perimetry in a pediatric population.
    Becker K; Semes L
    Optometry; 2003 Mar; 74(3):173-9. PubMed ID: 12645850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The usefulness of visual evoked potentials for the evaluation of visual pathways in children and adolescents with selected neuro-ophthalmological syndromes. (Summary of the doctor of medicine degree dissertation)].
    Bernardczyk-Meller J
    Klin Oczna; 1998; 100(5):289-94. PubMed ID: 9884525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A child with epilepsy in whom multifocal VEPs facilitated the objective measurement of the visual field.
    Yukawa E; Kim YJ; Kawasaki K; Taketani F; Hara Y
    Epilepsia; 2005 Apr; 46(4):577-9. PubMed ID: 15816954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between vision impairment and eye disease to vision-specific quality of life and function in rural India: the Aravind Comprehensive Eye Survey.
    Nirmalan PK; Tielsch JM; Katz J; Thulasiraj RD; Krishnadas R; Ramakrishnan R; Robin AL
    Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2308-12. PubMed ID: 15980215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Poor prognosis of visual outcome after visual loss from giant cell arteritis.
    Danesh-Meyer H; Savino PJ; Gamble GG
    Ophthalmology; 2005 Jun; 112(6):1098-103. PubMed ID: 15885780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The association between visual incompetence and spinal derangement: an instructive case history.
    Stephens D; Gorman F
    J Manipulative Physiol Ther; 1997 Jun; 20(5):343-50. PubMed ID: 9200051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The "sunglasses sign" predicts nonorganic visual loss in neuro-ophthalmologic practice.
    Bengtzen R; Woodward M; Lynn MJ; Newman NJ; Biousse V
    Neurology; 2008 Jan; 70(3):218-21. PubMed ID: 18195266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.